Based on the forecasted data for obstructive airway diseases medicine sales in South Korea from 2024 to 2028, the following year-on-year variations are observed:
- 2025: 2.53%
- 2026: 2.43%
- 2027: 2.36%
- 2028: 2.28%
Compound Annual Growth Rate (CAGR) over the five-year period (2024-2028) is approximately 2.40%.
Future trends to watch for include advances in medical treatments, government healthcare policies, and demographic shifts such as aging population, which could further influence the demand and sales of medicines for obstructive airway diseases in South Korea. Monitoring these factors will be essential for long-term strategic planning.
